Journal of Nanomaterials
Volume 2017 (2017), Article ID 5429063, 8 pages
https://doi.org/10.1155/2017/5429063

Research Article

Biocompatibility and Toxicity of Polylactic Acid/Ferrosoferric Oxide Nanomagnetic Microsphere

Hongzhao Xiang,¹ Yuanhua Mu,¹ Chengbo Hu,² and Xiaobing Luo³

¹College of Materials Science and Engineering, Chongqing Jiaotong University, Chongqing 400074, China
²Chongqing Key Laboratory of Environmental Materials & Remediation Technologies, Chongqing University of Arts and Sciences, Chongqing 402160, China
³College of Science, Chongqing University of Posts and Telecommunications, Chongqing 400065, China

Correspondence should be addressed to Hongzhao Xiang; xhzscu@163.com

Received 23 November 2016; Accepted 22 January 2017; Published 19 February 2017

Academic Editor: Vidyadhar Singh

Copyright © 2017 Hongzhao Xiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Magnetic targeted drugs delivery system (MTDDS) is a new targeted drug system, which can greatly reduce the dosage and improve the therapeutic efficiency of medicine. Currently superparamagnetic ferric oxide plays important function as targeted drug in the treatment of tumors, but cytotoxicity was still regarded as side effect in the process of drug. In this paper, we take advantage of drug carrier (ferric oxide) toxicity controlling cancer cell growth in cancer treatment, increasing targeted drug efficiency. We applied the modified chemical precipitation method to prepare polylactic acid (PLA) coated high-purity superparamagnetic Fe₃O₄ nanoparticles for targeted drug, characterized PLA/Fe₃O₄ microspheres physical and chemical properties, and then investigated cytotoxicity influence of PLA/Fe₃O₄ nanomagnetic microspheres as carrier for normal liver cells (7701) and liver cancer cells (HePG2) in different concentration; results of MTT and hemolysis and micronucleus test showed that carrier restrained the growth of HePG2 in special concentration, meanwhile the proliferation rate of liver cells was not affected. The study demonstrates that compared with liver cell, liver cancer cells (HepG2) are easy to be disturbed by PLA/Fe₃O₄ nanomagnetic microsphere, which have higher sensitivity and absorption ability. We hope to take advantage of the susceptible property of cancer cells for carriers to improve targeted drug function.

1. Introduction

Currently magnetic nanoparticles play important function as targeted drug in the treatment of tumors, which easily control the site of drug delivering. The drug can aggregate in lesion site for inhibiting and eliminating tumor growth, besides reducing the dosage of no lesion and thus lowering the side effect of drug on normal tissue [1–3]. Among them, superparamagnetic ferric oxide (Fe₃O₄, -Fe₂O₃, and CO-Fe₂O₄) received special attention, in part due to their magnetic properties, crystal structure, chemical stability, and decreased toxicity (LD50 2000 mg/kg, far higher than the dosage of clinical application). In order to further enhance targeted drug capacity of nanomagnetic particles [4, 5], scientists carry out study from three aspects: () selecting appropriate polymer as membrane coating particles, which help to increase dispersion and biocompatibility of microsphere; () modifying the surface, as nanoparticles may bond with kinds of functional group (-OH, -COOH, -NH₂, -CHO, etc.) on the surface of material, which are beneficial for connecting important bioactive substance (such as enzyme, cell, and drug) by adsorption or covalent bonding way; () improving particles superparamagnetic properties by adjusting diameter of microsphere, thickness of polymer membrane, and so on, which easily lead to targeted drug separation and tropism under magnetic field.

Preparation way of Fe₃O₄ nanomagnetic particles usually includes chemical precipitation, oxidation, and pyrolysis method, in which chemical precipitation method is the frequently used method for preparing Fe₃O₄ nanomagnetic particles. Polyester (polycaprolactone, polylactide) is widely used functional biomaterial with good biocompatibility and biodegradability, which often acts as membrane coating on the surface of magnetic particles. Magnetic microspheres coated by polyester have the very good application prospect in biological medicine. Utkan et al. [6] adsorbed glycolic acid on the surface of n-Fe₃O₄ by electrostatic effect and catalyzed CL graft reacting with the terminal hydroxyl through Sn(oct)₂, and magnetic component content was about 10–40% in the magnetic polymer microspheres. In the DMSO solution, PCL has the upper critical solution temperature (UCST) at 35°C, and the PCL lattice should be destroyed if above the temperature, meanwhile changing solubility, permeability, and other properties. 35°C is close to the temperature of the human body and therefore has a potential application in controlled drug release. In addition, Ni and Ramanujan [7] used similar way that initiated lactide (LA) reaction. In these experiments, researchers usually pay more attention to toxicity effect of drug delivering, releasing process on the cell or tissue in lesion, and biocompatibility of drug carriers. Today there are more researches on polyethylene glycol (PEG), polylactic acid (PLA), and/or poly-ε-caprolactone (PCL) for coating nanoparticles in the internal and external environment [8–16]. The toxicity reduction in human fibroblast cell was reported with superparamagnetic particles coated with pullulan in human skin fibroblast [17]. But few people take notice that carrier materials have certain potential of toxicity effect for cancer cell growth in targeted drug. In this study, at first we prepared Fe₃O₄ magnetic nanoparticle coated by PLA and then characterized structure, morphology, and biocompatibility of PLA/Fe₃O₄ microsphere; lastly it was investigated whether or not PLA/Fe₃O₄ nanomagnetic microspheres as carrier cause cytotoxicity for growth of normal liver cells and liver cancer cells. This paper focused on toxicity effect of drug carrier to cancer cell proliferation for increasing targeted drug efficiency.

2. Materials and Methods

2.1. Materials

Ferrous chloride tetrahydrate (FeCl₂·4H₂O), ferric chloride hexahydrate (FeCl₃·6H₂O), and hexamine were the products of the Chengdu Changzheng Chemical Reagent Company; oleic acid was obtained from Sichuan Guoguang Chemical Plant; PLA was purchased from Chengdu Lianhe Chemical Reagent Company.

2.2. Synthesis of PLA/Fe₃O₄ Microsphere

n-Fe₃O₄ was synthesized with the chemical precipitation method (see (1)). A certain amount of FeC1₃·6H₂O 1.7 g and FeCl₂·4H₂O 0.6 g (Fe³⁺ : Fe²⁺ = 2 : 1) was dissolved in deionized water and added hexamine. Subsequently the solution was poured into a three-mouth flask, with nitrogen protection, and heated to 80°C, and then ammonia solution was dropped to adjust pH to 10-11, keeping temperature at 80°C for 1 h under vigorous stirring, and gained black n-Fe₃O₄ crystals. Then oleic acid was added, under 80°C for 0.5 h, and cooled to room temperature. Excess ammonia was neutralized with hydrochloric acid to pH 7, n-Fe₃O₄ isolated by centrifugation and magnet processes, and n-Fe₃O₄ washed with ethanol three times to remove excess oleic acid and hexamine. Finally the crystals were collected and dried in a vacuum oven at 60°C.

PLA/Fe₃O₄ microspheres are prepared as follows: at first 0.5 g PLA was dissolved in 10 mL dichloromethane, then solution was put into three-neck bottle, 0.2 g Fe₃O₄ was added, and solution was stirred and heated at 55°C for one hour and then centrifuged for 5 minutes. The upper layer of the supernatant liquid was decanted and the precipitates were carefully transferred into a beaker. Finally, it was washed several times with distilled water and ultrasonicated and obtained the suspension of n-PLA/ Fe₃O₄ microspheres.

2.3. Instruments

X-ray diffraction (XRD) patterns of the samples were characterized in a Philips X’Pert Pro X-ray diffractometer (Philips, Netherlands). All the samples were irradiated with monochromatized CuKα radiation ( nm). A continuous scan rate of 5°min⁻¹ from 5° to 80° of 2θ was used for samples. Tube voltage and current were 40 kV and 40 mA, respectively. The functional groups were identified by Fourier transformed infrared (FTIR) spectra recorded using a Nicolet 6700 in transmission mode in the range 4000–400 cm⁻¹ using the KBr pellet method. Transmission electron microscope (TEM) was obtained with a JEOL-2010 (Japan) microscope using an accelerating voltage of 200 kV. PLA/Fe₃O₄ microspheres were observed by scanning electron microscopy (SEM) (S-450; Hitachi Ltd, Tokyo, Japan).

2.4. Cell and Animal Testing

Cells: human liver cells 7701 and human liver cancer cell HepG2 were provided by Sichuan Provincial People’s Hospital, the research center of freezing and thawing. There were 60 Kunming mice: 4 weeks old, SPF grade, half male and half female, weight () g, and provided by medical experimental animal center of Huaxi Medical Central Sichuan University (license number: SYXK 2012-0043). There were 14 New Zealand rabbits, male and female, provided by Sichuan University Animal Center (certificate number: 33-016). MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] was purchased from Sigma (St Louis, MO). The cell experiment was completed in the Nanotechnology Central of Sichuan University.

In order to study PLA/Fe₃O₄ nanomagnetic microsphere biocompatibility and cytotoxicity, we applied MTT assays in vitro to investigate proliferation of samples. First, the 7701 cell and HepG2 cell concentration were adjusted to 1 × 10⁵/mL and inoculated on a 96-well culture plate at 100 μL/well. The samples were cultured in the culture box at 37°C under saturated humidity and 5% CO₂ condition. The supernatant was discarded after 24 hours, and then the culture solution was added; besides primary concentration of PLA/Fe₃O₄ nanomagnetic particle solution was diluted up to 2, 5, 10, 15, 20 times. 7701 cell and HepG2 cell were cultured in the magnetic field. The DMEM group was used as the negative control, and a 0.7% polyacrylamide monomer solution was used as the positive control. Each sample group comprising nine wells was cultured for 72 hours, and 20 μL of MTT was then added to each well and vibrated for 10 minutes. The absorbance value was measured at 493 nm using an immunoenzyme labeler.

The relative cell activity rate was calculated as follows: relative growth rate % = OD (optical density) absorbance data of sample/OD absorbance data of negative control × 100%. The relative growth rate value was converted into six levels, as indicated in Tables 1 and 2. Levels 0-1 are acceptable, whereas level 2 should be assessed comprehensively considering cell morphology, and levels 3–5 are unacceptable.

Table 1: Results of MTT test of PLA/ Fe₃O₄ magnetic microspheres for 7701 cell.

Group
A490 ()
Inhibition rate (%)
Relative growth rate (%)
Toxicity grading

Negative control (DMEM)

100
0

5% PLA/Fe₃O₄ nanomagnetic fluid

1
99
0

25% PLA/Fe₃O₄ nanomagnetic fluid

−2
102
0

50% PLA/Fe₃O₄ nanomagnetic fluid

2
98
1

75% PLA/Fe₃O₄ nanomagnetic fluid

−3
103
0

100% PLA/Fe₃O₄ nanomagnetic fluid

4
96
1

Positive control (polyacrylamide)

76
24
4

versus positive control group.

Table 2: Results of MTT test of PLA/Fe₃O₄ nanomagnetic microspheres for HePG2 cell sequence.

Group
A 490 nm ()
Inhibition rate (%)
Relative growth rate (%)
Toxicity grading

Negative control (DMEM)

100
0

5% PLA/Fe₃O₄ nanomagnetic fluid

19
81
1

25% PLA/Fe₃O₄ nanomagnetic fluid

15
85
1

50% PLA/Fe₃O₄ nanomagnetic fluid

36
64
2

75% PLA/Fe₃O₄ nanomagnetic fluid

23
77
1

100% PLA/Fe₃O₄ nanomagnetic fluid

40
60
2

Positive control (polyacrylamide)

80
20
4

, versus negative control group.

Hemolysis test: a 10 mL blood sample was taken from a New Zealand rabbit (male, 2.1 kg), and 0.5 mL of 20 g/L potassium oxalate was added to sample. Fresh rabbit blood was diluted (dilution ratio 8 mL blood to 10 mL normal saline). n-Fe₃O₄ microspheres were washed twice with distilled water, dried, and suspended using normal saline (final concentration 0.1 g/mL). Normal saline was used as the negative control and distilled water as the positive control. Each group consisted of three test tubes. There was a suspension of the materials to be tested, and 10 mL normal saline and 10 mL distilled water were added to each tube, which was then placed in a 37°C water bath for 30 minutes. Diluted fresh rabbit blood (0.2 mL) was added to each tube, which was replaced to the 37°C water bath for 60 minutes. Then each tube was centrifuged in a dry centrifuge trunnion for 5 minutes at 2500 rpm; the supernatant was then removed and OD values were measured with a spectrophotometer. Absorbance values of each group were measured at 545 nm in hemolytic test. The hemolysis rate (%) = (OD absorbance data of sample − OD absorbance data of negative control)/(OD absorbance data of positive control − OD absorbance data of negative control) × 100%. If the hemolytic rate is less than 5%, the material will have no hemolytic effect and conform to the requirements of the hemolytic test for biomaterials.

Micronucleus assay: 60 Kunming mice were divided into six groups; each group includes ten mice, aged 4 weeks and weighing 20–22 g, (half male and half female). Injecting PLA/Fe₃O₄ suspension into mice abdomen, the dosage groups were 5, 2.5, 1.25, and 0.625 mg/kg. The positive control group used cyclophosphamide (40 mg/kg) for abdominal injection and the negative control group used normal saline for abdominal injection. The 30-hour injection method was applied: a 24-hour interval between two injections, then a 6-hour waits after the second injection, after which time the mice were killed by cervical vertebra dislocation. Narrow smear of the femur was treated by methanol for 5 min and then observed after Giemsa straining. The micronucleus test includes counting micronucleus number in each of the 1000 polychromatic erythrocytes of mouse, calculating the micro-containing rate of cells. The result was expressed (%) and significant difference checked among the groups based on Poisson distribution method.

3. Results and Discussion

3.1. Characterization of PLA/Fe₃O₄ Nanoparticle

3.1.1. XRD Analysis

In Figure 1, the crystal structure of pure Fe₃O₄ and PLA coated Fe₃O₄ microspheres was analyzed by XRD. In this figure, Fe₃O₄ crystal corresponds with face centered cubic (space group: Fd-3m), and lattice parameters of Fe₃O₄ are similar to the data of the International Centre for Diffraction Data [JCPDS: 65-3107]. The peak broadening of the XRD pattern can deduce diameter of particles, and according to the Scherrer formula, we can calculate average crystal size, about 40 nm. The intensity of the diffraction peak of (311) plane is stronger than the other peaks. The polymer coated magnetic nanoparticle shows similar XRD peaks, without any peak shift when compared to pure Fe₃O₄ nanoparticle. The characteristic peaks of PLA are about 17.8°, and polymer membrane coated particles’ surface, whose factors disturb high degree of crystalline and sharpness of peaks.

Figure 1: XRD pattern for the nanostructure Fe₃O₄ (a) and PLA/Fe₃O₄ (b).

3.1.2. FTIR Analysis

Figure 2 corresponds to the FTIR spectrum of pure Fe₃O₄, PLA, and PLA coated Fe₃O₄ nanomagnetic microspheres, which were measured in the range of 400–4000 cm⁻¹. See Figure 2, and pure Fe₃O₄ crystal shows the broad and strong absorption peak at 574 cm⁻¹, which corresponds with Fe-O bond of Fe₃O₄ crystal [18–20]. A broad peak at 3405 cm⁻¹ represents the O-H stretching vibration with the presence of water molecules. No other extra peaks were observed and this confirms the high purity of uncoated magnetic nanoparticle.

Figure 2: FTIR spectra for the Fe₃O₄ (a), PLA (b), and PLA/Fe₃O₄ (c).

PLA coated Fe₃O₄ magnetic microsphere: the peak at 1180 cm⁻¹ represents the vibration of the C-O group, and another peak at 1759 cm⁻¹ corresponds to the C=O stretching vibration, maybe due to the LA molecule coating the surface of the Fe₃O₄ nanoparticles, so it further confirms the modification of the surface on magnetite nanoparticles by hydrophilic molecules, which facilitate the anisotropic crystal growth. The broad peak at 3400–3450 cm⁻¹ belongs to the O-H stretching vibration of hydroxyl groups. The slight shifts in the Fe-O bond are in the range 480–590 cm⁻¹ for amine and polymer coated magnetic nanoparticles, and it may be due to the hexamine or the polymers coating the nanoparticles, which can enhance stabilization through some physical interaction on the surface of Fe₃O₄ [21]. These results confirm the successful wrapping hexamine and the polymers on the surface of the Fe₃O₄ nanoparticles.

3.1.3. TEM/SEM Observation

Figures 3 and 4 are the TEM images of pure Fe₃O₄ particles and SEM of PLA/Fe₃O₄ nanomagnetic particles. Photos reveal that diameter of Fe₃O₄ nanomagnetic particles is about 40–50 nm, and statistics were gathered from more than one hundred particles, which are consistent with calculation result of the Scherrer formula based on the characteristic peak of XRD, mentioned above.

Figure 3: TEM images of n-Fe₃O₄ particles.

Figure 4: SEM image of PLA/Fe₃O₄ magnetic microspheres.

The SEM image of PLA coated Fe₃O₄ magnetic nanoparticles: Figure 4 shows that the monodispersed spherical nanoparticles are around 400–500 nm in size. Microsphere size controlling is key elements of targeted drug. Reducing particle size can improve the dispersed stability of the microspheres but affects magnetic strength and targeting ability to transport. Furthermore, increasing size of microspheres can help to form embolism near the tumor vascular and reduce nutrient supplying tumors. In this experiment, size of Fe₃O₄ magnetic microspheres ranges from 400 to 500 nm, and each microsphere consists of many small Fe₃O₄ crystals. The aim of loading drug and gene, polylactic acid (PLA) coating Fe₃O₄ with oleic acid (PEI), can be realized to modify and enhance the loading ability of magnetic microsphere for drug to improve the transportation efficiency [22].

Some researchers applied coprecipitation method to prepare microsphere. Preparation of Fe₃O₄, precipitation of polymer, and coating nanoparticles are in the same environment. Polymer can be used to reduce aggregation and improve dispersibility of particles by changing the intrinsic properties of magnetic nanoparticles such as size, surface charge, and reactivity. The growth of nanocrystal can be controlled by the interface with organic components or polymer in one-step synthesis. In some experiments, researchers need to modify surface of nanoparticles with several organic and inorganic components before connecting with polymer; they usually divide synthesis into several steps, which are favorable to control reaction condition.

We investigated cytotoxicity influence of PLA/Fe₃O₄ nanomagnetic microspheres as carrier, hoping to decrease influence of other organic and inorganic components as possible. In one-step method, Fe₂O₃ particles, surfactant, and organic components can be introduced in microsphere together, making it difficult for separation and disturbing result of cytotoxicity test. On the contrary, two-step method can easily control precipitating of n-Fe₃O₄, crystal growth, modification, washing, and drying process.

Besides hexamine was added in the process of preparing Fe₃O₄ nanoparticles. Adding surfactant is to reduce the surface energy and enhance the formation of monodispersed spherically shaped nanoparticles, which can control the growth of spherical Fe₃O₄. Hexamine contains one or more functional group such as amide, hydroxyl, and carboxyl groups, which can act as the reaction site to enhance the reaction rate and fine orientation on the surface of Fe₃O₄. The kinetics of crystal growth leads to the uniform distribution of agglomeration free nanoparticles. When the particles exceed their critical size, the hexamine molecules act not only as shape controlling agents but also as stabilizing agents to control the growth of the magnetic nanoparticles.

3.2. Toxicity and Biocompatibility Study In Vitro and In Vivo

3.2.1. MTT Test

Biocompatibility and toxicity of PLA/Fe₃O₄ nanomagnetic microspheres were evaluated by MTT (cytotoxicity test), hemolysis test, and micronucleus test.

Tables 1 and 2 show result of MTT of PLA/Fe₃O₄ microspheres for 7701 cell and HePG2 cell. Table 1 indicates that cytotoxicity of PLA/Fe₃O₄ microsphere has no effect on growth of normal liver cell at low concentration; Table 2 shows that toxicity grade of PLA/Fe₃O₄ microsphere ranges from 1 to 2, as mentioned above, and at the level of 2, survival and proliferation of cell not only consider toxicity grade, but also assess cell’s morphology comprehensively, which means that growth of HepG2 is easy to be disturbed by PLA/Fe₃O₄ nanomagnetic microsphere at special concentration.

We investigated relationship between the different concentration of PLA/Fe₃O₄ magnetic nanoparticles and inhibition rate for liver cancer cell HepG2 (see Figure 5). PLA/Fe₃O₄ nanomagnetic microspheres used as drug carrier have no obvious toxicity to normal liver cells but inhibited liver cancer cells proliferation, which can help targeted drugs to treat cancer and increases the efficacy of the drugs.

Figure 5: Relationship between PLA/Fe₃O₄ magnetic microspheres concentration and hepatocyte HePG2 activity.

3.2.2. Hemolysis Test

The hemolytic test is considered to be a supplementary test for assessment of cytotoxicity. It is used to evaluate if erythrocytes should dissolve and release hemoglobin after direct contact of the biomaterial with blood. It can be a sensitive measure of the biomaterial influence on erythrocytes and plays an important role in evaluation of biological safety. According to Table 3, introduced data of in vitro hemolysis test into the formula of hemolysis [7], result showed that hemolytic data of PLA/Fe₃O₄ nanomagnetic microsphere was 0.62%, far less than the standard (5%), and showed no hemolysis response, and the requirements of the hemolytic test were met in biomaterials.

Table 3: Results of hemolysis test of PLA/Fe₃O₄ magnetic nanoparticles extract liquid.

Group
value
Mean value

1
2
3

Negative control (physiological saline)
0.018
0.017
0.016
0.0173

Experimental
0.020
0.024
0.023
0.0221

Positive control (distilled water)
0.787
0.779
0.770
0.7810

3.2.3. Micronucleus Test

The micronucleus test is a strategy to rapidly assess chromosomal damage and interference with mitosis caused by biomaterials. See Table 4; the test found no significant difference for micronucleus formation of the mice in bone marrow between the material and the negative control group. However, a significant difference for data of the positive control group was noted. Based on these data, the experimental material does not induce deformations or mutations.

Table 4: Results of micronucleus test of PLA/Fe₃O₄ nanomagnetic fluid ().

Group
Numbers of polychromatocytes
Numbers of micronucleuses in polychromatocytes
Micronucleus rates (%)

Negative control (physiological saline)
10000
26
24

5.00 g/Kg PLA/Fe₃O₄ nanomagnetic fluid
10000
24
23

4.00 g/Kg PLA/Fe₃O₄ nanomagnetic fluid
10000
22
21

2.50 g/Kg PLA/Fe₃O₄ nanomagnetic fluid
10000
20
19

1.25g/Kg PLA/Fe₃O₄ nanomagnetic fluid
10000
21
22

Positive control (cyclophosphamide)
10000
291
289

3.3. Discussion

Magnetic targeted drugs delivery system (MTDDS) is a new targeted drug system in recent years, which have the immense potential to treat some diseases, especially malignant tumors and other major diseases. MTDDS method can reduce the dosage and side effects and improve the therapeutic efficiency of medicine. Usually magnetic targeted drug delivery system consists of magnetic polymer microspheres and drug, and drug combines with microspheres by physical adsorption, entrapment, and chemical bonding methods. Most of drug loading microspheres play function through arterial injection, and then microspheres were placed and aggregated in lesion position under effect of the magnetic field, take advantage of embolism effect, and release drug, thereby achieving the purpose of treatment. Thus MTDDS can greatly reduce the dosage and side effects in the treatment of disease and improve the therapeutic efficiency. In 1960, Freeman first reported that the crystal (5–100 nm) of iron was introduced into the vascular system and iron accumulated in special part of the body under controlled external magnetic field. Turcu and colleagues [23] prepared magnetic polymethyl methacrylate microspheres containing indomethacin, intravenously injected, and employed magnetic field in the rat tail for 60 min; drug concentration in the rat tail was 60 times higher than that of control group. In recent years, magnetic polymer microspheres as drug carrier for liver cancer therapy attracted scientist’s attention [24, 25]. Lbbe and colleagues first applied magnetic polymer microsphere in clinical trials, they used magnetic microspheres (100 nm) containing epirubicin treating 14 patients with advanced stage hepatoma, and results showed that the method of cure reduces the side effect of drugs greatly and, at the same time, realized aggregation of microspheres in targeted area under the magnetic field. However the MRI showed that part of microspheres were detained in the lungs.

There are still some problems for Fe₃O₄ magnetic microsphere as carrier being used in the targeted drug field, especially cytotoxicity. Many studies have demonstrated toxicity of Fe₃O₄ nanoparticles in biological systems. Currently it is not clear whether Fe₃O₄ alone or combination of other harmful agents (polymer membrane and functional group) causes the danger. Some scientists deduced the phenomenon to the ferric oxide nanoparticle releasing active oxygen and causing oxidative stress and inflammation by the RES (reticuloendothelial system).

So researchers focus on drug release; lowering or eliminating toxicity of targeted drug often follows three elements: () the skeleton material in the body can be metabolism and metabolites ought to have no toxicity and be excreted in a certain period; () diameter of nonbiodegradable particles (Fe₃O₄) contained in microspheres has to be less than 20 μm [26]; () magnetic polymer microspheres should have strong magnetic response potential and high surface area. But they often ignored the value for toxicity of drug carrier. This study investigated influence of carrier toxicity for proliferation of liver cells 7701 and liver cancer cell HepG2 at different concentrations. MTT results showed that carrier restrained the growth of HePG2 in special concentration. Meanwhile, the proliferation rate of liver cells was right. We attributed this result to two factors: () liver cancer cells have high sensitivity. Compared with liver cell, HepG2 is easy to be disturbed by PLA/Fe₃O₄ nanomagnetic fluid toxicity, so the growth of HepG2 is inhibited; () absorption ability of cancer cell is stronger than normal cells if cocultured with PLA/Fe₃O₄ nanomagnetic solution. So we can take advantage of drug carrier toxicity controlling cancer cell growth in cancer treatment.

In the paper, Fe₃O₄ nanoparticles are modified with oleic acid, its surface bond with oleic acid chains, and hydroxyl group, so it is amphipathy. If n-Fe₃O₄ were placed in the PLA solution environment, amphipathy of Fe₃O₄ nanoparticles tends to be self-assembled by bonding with carboxyl group and hydroxyl groups on the surface of Fe₃O₄ nanoparticles; surface charge of PLA/Fe₃O₄ microspheres can affect the dispersion, magnetic strength, and size of microspheres in solvents.

4. Conclusions

In the study, we successfully prepared PLA/Fe₃O₄ nanomagnetic microsphere. Biocompatibility was evaluated by a series test in vivo and in vitro, MTT experiments showed that the toxicity of the material in normal liver cell was between Grade 0 and Grade 1, Fe₃O₄ nanomagnetic microsphere inhibited liver cancer cell proliferation, the material lacked hemolysis activity, and micronucleus testing showed no genotoxic effects. Test demonstrated that the Fe₃O₄ nanoparticle had no effect on the main organs and blood biochemistry in mice, its performance conforms to clinical requirements, and its biocompatibility conforms to the standard for medical material. We investigated toxicity effect of drug carrier for different cells. As liver cancer cells are susceptible to PLA/Fe₃O₄ nanomagnetic fluid toxicity, PLA/Fe₃O₄ carrier has certain potential to restrain liver cancer cells growth. So applying PLA/Fe₃O₄ nanomagnetic microsphere as drug carrier not only has good targeting capacity, but also helps to control cancer cell growth by toxicity effect of carrier and enhance targeted drug efficiency.

Competing Interests

The authors declare that they have no competing interests.

Acknowledgments

This work was financially supported by Research Foundation of the Chongqing Jiaotong University (16JDKJC-A035) and Chongqing Post-Doctoral Study Foundation (Xm2016128).

References

L. H. Reddy, J. L. Arias, J. Nicolas, and P. Couvreur, “Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications,” Chemical Reviews, vol. 112, no. 11, pp. 5818–5878, 2012.

L. Biao, G. Jian-guo, W. Qi et al., “Preparation of nanometer cobalt particles by polyol reduction process and mechanism research,” Materials Transactions, vol. 46, no. 4, pp. 1865–1867, 2010.

Z. Ying, J. Shengming, Q. Guanzhou et al., “Preparation of ultrafine nickel powder by polyol method and its oxidation product,” Materials Science and Engineering B, vol. 122, no. 1, pp. 222–225, 2013.

C.-C. Huang, K.-Y. Chuang, C.-P. Chou et al., “Size-control synthesis of structure deficient truncated octahedral Fe3−δO₄ nanoparticles: high magnetization magnetites as effective hepatic contrast agents,” Journal of Materials Chemistry, vol. 21, no. 20, pp. 7472–7479, 2011.

H. T. Hai, H. Kura, M. Takahashi, and T. Ogawa, “Facile synthesis of Fe₃O₄nanoparticles by reduction phase transformation from γ-Fe₂O₃ nanoparticles in organic solvent,” Journal of Colloid and Interface Science, vol. 341, no. 1, pp. 194–199, 2010.

G. Utkan, F. Sayar, P. Batat, S. Ide, M. Kriechbaum, and E. Pişkin, “Synthesis and characterization of nanomagnetite particles and their polymer coated forms,” Journal of Colloid and Interface Science, vol. 35, no. 2, pp. 372–379, 2011.

S. Ni and R. V. Ramanujan, “Doxorubicin loaded PLA coated iron oxide nanoparticles for targeted drug delivery,” Materials Science and Engineering C, vol. 30, no. 7, pp. 484–490, 2010.

S. Liu, Y. Han, R. Qiao et al., “Investigations on the interactions between plasma proteins and magnetic iron oxide nanoparticles with different surface modifications,” Journal of Physical Chemistry C, vol. 114, no. 49, pp. 21270–21276, 2010.

A. J. Cole, A. E. David, J. Wang, C. J. Galbán, H. L. Hill, and V. C. Yang, “Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting,” Biomaterials, vol. 32, no. 8, pp. 2183–2193, 2011.

N. Arsalani, H. Fattahi, and M. Nazarpoor, “Synthesis and characterization of PVP-functionalized superparamagnetic Fe₃O₄ nanoparticles as an MRI contrast agent,” Express Polymer Letters, vol. 4, no. 6, pp. 329–338, 2010.

D.-H. Zhang, G.-D. Li, J.-X. Li, and J.-S. Chen, “One-pot synthesis of Ag–Fe₃O₄ nanocomposite: a magnetically recyclable and efficient catalyst for epoxidation of styrene,” Chemical Communications, no. 29, pp. 3414–3416, 2008.

A. Sugunan, H. C. Warad, M. Boman, and J. Dutta, “Zinc oxide nanowires in chemical bath on seeded substrates: role of hexamine,” Journal of Sol-Gel Science and Technology, vol. 39, no. 1, pp. 49–56, 2006.

W. Jiang, Z. Sun, F. Li et al., “A novel approach to preparing magnetic protein microspheres with core-shell structure,” Journal of Magnetism and Magnetic Materials, vol. 323, no. 5, pp. 435–439, 2011.

E. Iglesias-Silva, J. Rivas, L. M. León Isidro, and M. A. López-Quintela, “Synthesis of silver-coated magnetite nanoparticles,” Journal of Non-Crystalline Solids, vol. 353, no. 8-10, pp. 829–831, 2007.

Z. Zou, A. G. Xuan, Z. G. Yan, Y. X. Wu, and N. Li, “Preparation of Fe₃O₄ particles from copper/iron ore cinder and their microwave absorption properties,” Chemical Engineering Science, vol. 65, no. 1, pp. 160–164, 2010.

J. Liang, L. Li, M. Luo, J. Fang, and Y. Hu, “Synthesis and properties of magnetite Fe₃O₄ via a simple hydrothermal route,” Solid State Sciences, vol. 12, no. 8, pp. 1422–1425, 2010.

Y. Yin, S. Zhou, C. Min, and L. Wu, “Preparation of rattle-type magnetic mesoporous carbon spheres and their highly efficient adsorption and separation,” Journal of Colloid and Interface Science, vol. 361, no. 2, pp. 527–533, 2011.

W. Beck, C. G. Souza, T. L. Silva, M. Jafelicci, and L. C. Varanda, “Formation mechanism via a heterocoagulation approach of FePt nanoparticles using the modified polyol process,” The Journal of Physical Chemistry C, vol. 115, no. 21, pp. 10475–10482, 2011.

Y. Zhan, R. Zhao, F. Meng et al., “Oriented growth of magnetite along the carbon nanotubes via covalently bonded method in a simple solvothermal system,” Materials Science and Engineering B, vol. 176, pp. 779–784, 2011.

J. Töpfer and A. Angermann, “Nanocrystalline magnetite and Mn-Zn ferrite particles via the polyol process: synthesis and magnetic properties,” Materials Chemistry and Physics, vol. 129, no. 1, pp. 337–342, 2011.

B. Wang, B. Wang, P. Wei, X. Wang, and W. Lou, “Controlled synthesis and size-dependent thermal conductivity of Fe₃O₄ magnetic nanofluids,” Dalton Transactions, vol. 41, no. 3, pp. 896–899, 2012.

Z. Pu, M. Cao, J. Yang, K. Huang, and C. Hu, “Controlled synthesis and growth mechanism of hematite nanorhombohedra, nanorods and nanocubes,” Nanotechnology, vol. 17, no. 3, pp. 799–804, 2006.

R. Turcu, O. Pana, A. Nan, I. Craciunescu, O. Chauvet, and C. Payen, “Polypyrrole coated magnetite nanoparticles from water based nanofluids,” Journal of Physics D: Applied Physics, vol. 41, no. 24, Article ID 245002, 2008.

E. Maltas, M. Ozmen, H. C. Vural, S. Yildiz, and M. Ersoz, “Immobilization of albumin on magnetite nanoparticles,” Materials Letters, vol. 65, no. 23-24, pp. 3499–3501, 2011.

X. Wang, G. Xi, Y. Liu, and Y. Qian, “Controllable synthesis of PbSe nanostructures and growth mechanisms,” Crystal Growth & Design, vol. 8, no. 4, pp. 1406–1411, 2008.

M. Mahmoudi, A. Simchi, M. Imani, P. Stroeve, and A. Sohrabi, “Templated growth of superparamagnetic iron oxide nanoparticles by temperature programming in the presence of poly(vinyl alcohol),” Thin Solid Films, vol. 518, no. 15, pp. 4281–4289, 2010.